Diagnostic utility of BNP, corin and furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients

References

• American Diabetes Association. (2009). Standards of medical care in diabetes – 2009. Diabetes Care 32:S13–61
   PubMed Web of Science ®Google Scholar
• Bugge TH, Antalis TM, Wu Q. (2009). Type II transmembrane serine proteases. J Biol Chem 284:23177–81
   PubMed Web of Science ®Google Scholar
• Chen HH. (2007). Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!. J Am Coll Cardiol 49:1089–91
   PubMed Web of Science ®Google Scholar
• Chen S, Sen S, Young D, et al. (2010). Protease corin expression and activity in failing hearts. Am J Physiol Heart Circ Physiol 299:H1687–92
   PubMed Web of Science ®Google Scholar
• Creemers JW, Khatib AM. (2008). Knock-out mouse models of proprotein convertases: unique functions or redundancy?. Front Biosci 13:4960–71
   PubMed Web of Science ®Google Scholar
• Daniels LB, Maisel AS. (2007). Natriuretic peptides. J Am Coll Cardiol 50:2357–68
   PubMed Web of Science ®Google Scholar
• Devlin B, Risch N. (1995). A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311–22
   PubMed Web of Science ®Google Scholar
• Dong N, Chen S, Wang W, et al. (2012). Corin in clinical laboratory diagnostics. Clin Chim Acta 413:378–83
   PubMed Web of Science ®Google Scholar
• Dong N, Chen S, Yang J, et al. (2010). Plasma soluble corin in patients with heart failure. Circ Heart Fail 3:207–11
   PubMed Web of Science ®Google Scholar
• Dries DL. (2011). Process matters: emerging concepts underlying impaired natriuretic peptide system function in heart failure. Circ Heart Fail 4:107–10
   PubMed Web of Science ®Google Scholar
• Dries DL. (2007). Relevance of molecular forms of brain natriuretic peptide for natriuretic peptide research. Hypertension 49:971–3
   PubMed Web of Science ®Google Scholar
• Dries DL, Victor RG, Rame JE, et al. (2005). Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112:2403–10
   PubMed Web of Science ®Google Scholar
• Hooper JD, Scarman AL, Clarke BE, et al. (2000). Localization of the mosaic transmembrane serine protease corin to heart myocytes. Eur J Biochem 267:6931–7
   PubMedGoogle Scholar
• Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. (2011). Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide. Circ Heart Fail 4:114–20
   PubMed Web of Science ®Google Scholar
• Ichiki T, Boerrigter G, Huntley BK, et al. (2013a). Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. Am J Physiol Regul Integr Comp Physiol 304:R102–9
   PubMed Web of Science ®Google Scholar
• Ichiki T, Huntley BK, Burnett JC Jr. (2013b). BNP molecular forms and processing by the cardiac serine protease corin. Adv Clin Chem 61:1–31
   PubMed Web of Science ®Google Scholar
• Ichiki T, Huntley BK, Heublein DM, et al. (2011). Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation. Clin Chem 57:40–7
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–9
   PubMed Web of Science ®Google Scholar
• Jin QH, Ye WL, Chen HH, et al. (2014). Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitus. BMC Endocr Disord 14:27
   PubMed Web of Science ®Google Scholar
• McCullough PA, Omland T, Maisel AS. (2003). B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4:72–80
   PubMedGoogle Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–847
   PubMed Web of Science ®Google Scholar
• Motiwala SR, Januzzi JL Jr (2013). The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clin Pharmacol Ther 93:57–67
   PubMed Web of Science ®Google Scholar
• Peakall R, Smouse PE. (2012). GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research – an update. Bioinformatics 28:2537–9
   PubMed Web of Science ®Google Scholar
• Peakall R, Smouse PE. (2006). GenAlEx 6: genetic analysis in Excel. Population genetic software for teaching and research. Mol Ecol Notes 6:288–95
   Web of Science ®Google Scholar
• Peleg A, Ghanim D, Vered S, Hasin Y. (2013). Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2:159–65
   PubMedGoogle Scholar
• Pfister R, Sharp S, Luben R, et al. (2011). Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med 8:e1001112
   PubMed Web of Science ®Google Scholar
• Phelan D, Watson C, Martos R, et al. (2012). Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. PLoS One 7:e49259
   PubMed Web of Science ®Google Scholar
• Potter LR, Abbey-Hosch S, Dickey DM. (2006). Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47–72
   PubMed Web of Science ®Google Scholar
• Rame JE, Tam SW, McNamara D, et al. (2009). Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circ Heart Fail 2:541–8
   PubMed Web of Science ®Google Scholar
• Sawada Y, Suda M, Yokoyama H, et al. (1997). Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 272:20545–54
   PubMed Web of Science ®Google Scholar
• Semenov AG, Seferian KR. (2011). Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing. Clin Chim Acta 412:850–60
   PubMed Web of Science ®Google Scholar
• Semenov AG, Tamm NN, Seferian KR, et al. (2010). Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 56:1166–676
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
   PubMed Web of Science ®Google Scholar
• Takahashi T, Nakamura M, Onoda T, et al. (2009). Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis 207:298–303
   PubMed Web of Science ®Google Scholar
• Vodovar N, Séronde MF, Laribi S, et al. (2014). Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J 35:3434–41
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. (2004). Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–63
   PubMed Web of Science ®Google Scholar
• Wang W, Liao X, Fukuda K, et al. (2008). Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res 103:502–8
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2011). Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan Sixty-fourth World Health Assembly, Provisional agenda item 15, A64/INF.DOC./2. May 2011. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_ID2-en.pdf [last accessed 4 Dec 2014]
   Google Scholar
• World Health Organization (WHO). (2013). Cardiovascular diseases (CVDs) Fact Sheet, No. 317. March 2013. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/ [last accessed 4 Dec 2014]
   Google Scholar
• Wu Q, Xu-Cai YO, Chen S, Wang W. (2009). Corin: new insights into the natriuretic peptide system. Kidney Int 75:142–6
   PubMed Web of Science ®Google Scholar
• Wu F, Yan W, Pan J, et al. (2002). Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem 277:16900–5
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–239
   PubMed Web of Science ®Google Scholar